Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip J Clements

Showing results (21-30 of 93) with videos related to

Pageof 10
Sort By:
Journal of Scleroderma and Related Disorders|April 6, 2022
Coping profiles and health outcomes among individuals with systemic sclerosis: A latent profile analysis approachShelley E Condon, Scott C Roesch, Philip J Clements, et al.
The Journal of Rheumatology|July 15, 2003
Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6Peter A Merkel, Philip J Clements, John D Reveille, et al.
Case Reports in Rheumatology|March 29, 2017
A Rare Case of Digital Ischemia and Gangrene in ANCA-Associated Vasculitis with Review of the LiteratureRichard A Lau, Ramandeep Bains, Duminda Suraweera, et al.
Case Reports in Rheumatology|April 28, 2016
Fever, Myositis, and Paralysis: Is This Inflammatory Myopathy or Neuroinvasive Disease?Aneeta R Kiran, Richard A Lau, Kim M Wu, et al.
The Journal of Rheumatology|June 18, 2002
New onset systemic lupus erythematosus with pheochromocytomaAntony T H Lin, Yoon Min, Philip J Clements, et al.
Arthritis and Rheumatism|December 2, 2009
Rapamycin versus methotrexate in early diffuse systemic sclerosis: results from a randomized, single-blind pilot studyTien-I Karleen Su, Dinesh Khanna, Daniel E Furst, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Etiology unknown: Qualitative analysis of patient attributions of causality in sclerodermaShadi Gholizadeh, Julia H Drizin, Ingunn Hansdottir, et al.
The Journal of Rheumatology|October 10, 2008
Vitamin D, parathyroid hormone, and acroosteolysis in systemic sclerosisYolanda Braun-Moscovici, Daniel E Furst, Doron Markovits, et al.
Rheumatology (Oxford, England)|September 25, 2009
Minimally important differences in the Mahler's Transition Dyspnoea Index in a large randomized controlled trial--results from the Scleroderma Lung StudyDinesh Khanna, Chi-Hong Tseng, Daniel E Furst, et al.
Arthritis and Rheumatism|August 1, 2009
Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trialsSogol Amjadi, Paul Maranian, Daniel E Furst, et al.
Pageof 10

Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
Journal of Scleroderma and Related Disorders|April 6, 2022
Coping profiles and health outcomes among individuals with systemic sclerosis: A latent profile analysis approachShelley E Condon, Scott C Roesch, Philip J Clements, et al.
The Journal of Rheumatology|July 15, 2003
Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6Peter A Merkel, Philip J Clements, John D Reveille, et al.
Case Reports in Rheumatology|March 29, 2017
A Rare Case of Digital Ischemia and Gangrene in ANCA-Associated Vasculitis with Review of the LiteratureRichard A Lau, Ramandeep Bains, Duminda Suraweera, et al.
Case Reports in Rheumatology|April 28, 2016
Fever, Myositis, and Paralysis: Is This Inflammatory Myopathy or Neuroinvasive Disease?Aneeta R Kiran, Richard A Lau, Kim M Wu, et al.
The Journal of Rheumatology|June 18, 2002
New onset systemic lupus erythematosus with pheochromocytomaAntony T H Lin, Yoon Min, Philip J Clements, et al.
Arthritis and Rheumatism|December 2, 2009
Rapamycin versus methotrexate in early diffuse systemic sclerosis: results from a randomized, single-blind pilot studyTien-I Karleen Su, Dinesh Khanna, Daniel E Furst, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Etiology unknown: Qualitative analysis of patient attributions of causality in sclerodermaShadi Gholizadeh, Julia H Drizin, Ingunn Hansdottir, et al.
The Journal of Rheumatology|October 10, 2008
Vitamin D, parathyroid hormone, and acroosteolysis in systemic sclerosisYolanda Braun-Moscovici, Daniel E Furst, Doron Markovits, et al.
Rheumatology (Oxford, England)|September 25, 2009
Minimally important differences in the Mahler's Transition Dyspnoea Index in a large randomized controlled trial--results from the Scleroderma Lung StudyDinesh Khanna, Chi-Hong Tseng, Daniel E Furst, et al.
Arthritis and Rheumatism|August 1, 2009
Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trialsSogol Amjadi, Paul Maranian, Daniel E Furst, et al.
Pageof 10